Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-24 · accession 0001677418-25-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-11-24 | MEDP | BURWIG SUSAN E | EVP, Ops | S - Sale | $609.15 | -20.0K | 27.5K | -42% | -$12.18M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | S | D | 20,000 | $609.15 | 27,500 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $607.59 to $610.92. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |